China CDC

China CDC
CCDC Weekly – Weekly Reports: Current Volume (3)
2021-06-18 / No. 25
PDF of this issue
:: Policy Notes: Interpretation of the Protocol for Prevention and Control of COVID-19 in China (Edition 8)
:: Preplanned Studies: Willingness of the General Public to Receive the COVID-19 Vaccine During a Second-Level Alert — Beijing Municipality, China, May 2020
:: Perspectives: Caution About Truncation-By-Death in Clinical Trial Statistical Analysis: A Lesson from Remdesivir
:: Notes from the Field: Genome Characterization of COVID-19 Lineage B.1.1.7 Detected in the First Six Patients of a Cluster Outbreak — Shenzhen City, Guangdong Province, China, May 2021
:: Notes from the Field: Three Cases of COVID-19 Variant Delta With and Without Vaccination — Chengdu City, Sichuan Province, April–May, 2021
:: Notifiable Infectious Diseases Reports: Reported Cases and Deaths of National Notifiable Infectious Diseases — China, April, 2021

National Health Commission of the People’s Republic of China [to 19 Jun 2021]
June 19: Daily briefing on novel coronavirus cases in China
On June 18, 31 provincial-level regions and the Xinjiang Production and Construction Corps on the Chinese mainland reported 30 new cases of confirmed infections

China delivers additional batch of Sinovac vaccines to Philippines

China approves emergency use of domestic vaccines for 3-17 age group
Updated: 2021-06-15 | Xinhua
[See COVID – China above for detail]

National Medical Products Administration – PRC [to 19 Jun 2021]
Over 945m doses of COVID-19 vaccines administered in China
More than 945.1 million doses of COVID-19 vaccines have been administered in China as of Wednesday, the National Health Commission said on June 17.

China’s NMPA, Indonesian BPOM sign MoU on Regulatory Cooperation of Pharmaceutical Products and Cosmetics
In order to jointly respond to global public health challenges, China’s NMPA and Indonesian BPOM have agreed to strengthen regulatory cooperation.